The Supreme Court ruled in favor of Roundup weedkiller maker Bayer, blocking thousands of lawsuits alleging the product caused cancer due to federal regulations finding a cancer link unlikely. This decision is a victory for Bayer and the Trump administration, but a setback for plaintiffs.
The Supreme Court ruled 7-2 that Bayer cannot be sued over state-level claims regarding Roundup's cancer risks, stating federal law preempts such warnings. This is a major win for Bayer but a blow to the "Make America Healthy Again" movement and could have political repercussions for the Trump administration.
A proposed $7.25 billion settlement for Roundup cancer claims faces delays after an attorney moved the case to federal court, challenging its approval in Missouri. Bayer opposes the move, seeking to keep proceedings in state court.
Glyphosate is currently sprayed on cereal and pulse crops to dessicate them and make them easier to harvestA new trade deal with the EU could lead to restrictions on the use of the controversial weedkiller glyphosate on UK food crops.The full-spectrum herbicide, which kills almost every plant it touches, is often sprayed on wheat, oats and other cereal and pulse crops immediately before harvest to desiccate them and make them easier to handle. Continue reading...
The House of Representatives passed an amendment stripping controversial pesticide liability protections from the farm bill, 280-142, after bipartisan opposition from lawmakers and Make America Healthy Again advocates. The provisions would have shielded Bayer from lawsuits over its Roundup herbicide and glyphosate, which the WHO classified as probably carcinogenic in 2015. The broader farm bill passed 224-200 and now heads to the Senate.
The Supreme Court heard arguments Monday on whether to block thousands of lawsuits alleging Roundup causes cancer, with Bayer arguing federal EPA findings that glyphosate is not carcinogenic preempt state law claims. A Missouri man who developed non-Hodgkin's lymphoma after 20 years of using Roundup won a $1.25 million verdict, one of many cases against Bayer, which has set aside $16 billion for settlements.
